Representative before the EPO

Employment test 51 - 200 employees
Company dna maiwald patentanwalts gmbh
operating since 1995
Headquarter in Munich and 4 offices
active in Legal Services and IP Consulting

We have observed 7 EP applications Stefanie Parchmann has served for within the last five+ years. (We consider all applications which have an EP A1 publication dated after December 17, 2012). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP13166824

Semiconductor wafer with high thermal conductivity

IPC classification:
H01L 21/02, H01L 21/22, H01L 27/02, H01L 29/02, H01L 29/36, H01L 31/0352
Applicant:
MEMC Electronic Materials Inc
Agent:
Stefanie Parchmann, Maiwald Patentanwalts GmbH
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP15178631

HYDROGEN STORAGE BY REVERSIBLE HYDROGENATION OF PI-CONJUGATED SUBSTRATES

IPC classification:
C01B 3/00
Applicant:
Air Products and Chemicals Inc
Agent:
Stefanie Parchmann, Maiwald Patentanwalts GmbH
Status:
EXAMINATION REQUESTED
EP11825215

INHIBITOR OF HMGB PROTEIN-MEDIATED IMMUNE RESPONSE ACTIVATION

IPC classification:
A61K 31/7125, C12N 15/113
Agent:
Stefanie Parchmann, Maiwald Patentanwalts GmbH
Status:
PATENT GRANTED
EP15802302

METHODS AND SYSTEMS FOR DESIGNING PHOTOVOLTAIC SYSTEMS

IPC classification:
G06F 17/50, G06Q 10/04, G06Q 50/06
Agent:
Stefanie Parchmann, Maiwald Patentanwalts GmbH
Status:
Request for examination was made
EP15864424

SILK PERFORMANCE APPAREL AND PRODUCTS AND METHODS OF PREPARING THE SAME

IPC classification:
A61K 8/64, A61K 8/67, A61K 8/73
Agent:
Stefanie Parchmann, Maiwald Patentanwalts GmbH
Status:
Request for examination was made
EP15875540

PHARMACEUTICAL COMPOSITION FOR TREATING CANCER, CONTAINING LACTATE METAL SALT

IPC classification:
A61K 9/00, A61K 9/08, A61K 9/48, A61K 9/70, A61K 31/19, A61K 31/191, A61K 31/506, A61K 45/06, A23L 33/10
Agent:
Stefanie Parchmann, Maiwald Patentanwalts GmbH
Status:
Request for examination was made
EP16703409

INDUCED EXPRESSION OF BRAIN DERIVED NEUROTROPHIC FACTOR (BDNF) FOR TREATMENT OF NEUROMUSCULAR, NEURODEGENERATIVE, AUTOIMMUNE, DEVELOPMENTAL AND/OR METABOLIC DISEASES

IPC classification:
A61K 31/06, A61P 25/28
Agent:
Stefanie Parchmann, Maiwald Patentanwalts GmbH
Status:
Request for examination was made

Please Sign in to use this feature